SPOTLIGHT -
The Healthcare Technology Winners of 2017
The experts have weighed in. These are the healthtech companies that won 2017.
CRISPR Could Yield $25B in Revenues by 2030
Why Frost & Sullivan expects the genome-editing technology to be a financial boon.
Patients More Willing to Undergo Genetic Testing if Given Control of Their Data
State-level privacy policies have a substantial impact on incidence of genetic testing, according to a new study.
$50M Gift Establishes Precision Medicine Institute in Honor of Costco Co-Founder
Costco co-founder Jeffrey Brotman died in August, but friend says the new institute will be a lasting treatment to his generosity.
Direct-to-Consumer DNA Tests Face Scrutiny Amid Big Sales Push
DNA tests may be selling well in advance of the holidays. This week Senator Chuck Schumer cautioned about how they may use consumer genetic info.
Fighting Cancer with CAR T and Big Data
As therapies like Kymriah and Yescarta transform medicine, how can hospitals take advantage of analytics to improve processes and patient outcomes?
NIH Announces Partnerships for All of Us Program Awareness
The ambitious precision medicine initiative looks to sequence 1 million Americans to inform public health.
FDA Continues Embrace of Precision Medicine with Tumor Test Approval
In addition to the approval, the agency announced that it is streamlining the review process for NGS tumor tests.
Geisinger Announces National Precision Health Initiative
“I know of no other health system with such dedication to putting patients and their health first," the new Initiative's director said.
Gates Bets on Big Data in Alzheimer's Fight
“We need to use data better,” the billionaire wrote in a blog post announcing a huge investment.
Clinicians Will Need to Adjust to Precision Medicine
For centuries, population-based evidence has laid the foundation of healthcare. Precision medicine will change that.
VA Expands Testing Arrangement with Personal Genome Diagnostics
The testing company also stated that it raised $65 million in an ongoing funding round.
Cota and Memorial Sloan Kettering to Collaborate on Cancer Care
“With the genomic revolution...it’s increasingly important for providers to have a trusted data partner, and that is why MSK chose Cota.”
Progenity Raises $125M in Series B Financing
This windfall marks the third for a genomics company since Friday.
Counsyl Gets $80M Birthday Present
The genetic testing company celebrated its birthday in style, adding a new board member and a huge investment.
FDA to Streamline Review Process for DTC Genetic Tests
The move could be a massive boon for the burgeoning industry.
CHOP and Edico Team Up for Record-Setting Genome Analysis
Children’s Hospital of Philadelphia and the next-generation sequencing firm analyzed 1,000 genomes in under 3 hours.
FDA Approves Second CAR T-cell Therapy
The "new era of personalized cancer therapy” is here: effective, novel, and expensive.
Precision for Medicine Acquires Molecular Diagnostics Lab Epiontis
The buyer touted the lab company's "unique epigenetic technology and expertise."
Talking Value, Culture, and CAR-T with the CMO of Mayo Medical Labs
Curtis Hanson, MD, sat down to discuss the role of laboratory testing in the pursuit of value-based care.
23andMe Gets Large Investment, Announces Survey Findings
The American public is interested in consumer DNA testing, but lacking in knowledge about genetics and privacy.
Precision Medicine Treatments are Coming, but Who Will Pay?
Precision Medicine Group today launched its Precision Value & Health initiative to try to find ways to address that question.
Oxitec to Build Massive Mosquito Egg Production Unit in UK
The unit will be capable of producing up to a billion genetically-modified mosquito eggs per week.
LifeMine Cashes in on Precision Medicine, Abbott Extends Deadline to Cash Out on Alere
LifeMine champions its “genomically-enabled drug discovery engine” that combines artificial intelligence with synthetic biology.
Watson for Oncology is Learning Daily, but Still Lacking Validation
“Sometimes we realize, 'Watson got that one right and we got it wrong," one of its trainers at MSKCC said. Still, it has work to do.
Kymriah: an (Expensive) Precision Medicine Breakthrough
The FDA, for the first time, approved a gene therapy with a good chance of bringing remission for young cancer patients.
Syapse's Jonathan Hirsch on Barriers, Coups, and Hope in Precision Medicine
"We're in Silicon Valley...if we were in this for the money, there are a lot of other things we could be doing, everyone at this company. The reason we're here is the impact on patients."
"C-Suite" Q&A: Defining Precision Medicine with Jonathan Hirsch
The "C-Suite" is in quotes because Jonathan Hirsch settles for just being the Founder and President of his company, Syapse
Upstarts Get a Stage at MedCity CONVERGE
The firms utilized everything from novel devices to advanced analytics to dogs.
Stanford Doctors Urge Realism Towards Machine Learning
"Whether such artificial-intelligence systems are ‘smarter’ than human practitioners makes for a stimulating debate—but is largely irrelevant," they write.